This study was aimed to investigate the effects of raloxifene on intact parathyroid hormone ( PTH ) level and bone mineral density ( BMD ) for @ months in women on hemodialysis and women with chronic kidney disease stage @ not dependent on dialysis to determine its effect on secondary hyperparathyroidism and osteoporosis .